BioPivot Review: Questions to Resolve Before Paying for a Compounded GLP-1 Program

Before choosing a BioPivot plan, ask a question that its headline price cannot answer: what happens to your payment if the clinician decides treatment is not appropriate? The homepage advertises a first review at no charge and $0 if you are not approved. The cancellation policy instead describes retaining a $59 consultation fee after an unsuccessful clinical review. That discrepancy makes a written explanation of the actual checkout terms more useful than a general assurance that enrollment is straightforward.

BioPivot, LLC presents itself as a U.S. telehealth technology platform connecting patients with independent clinical providers and pharmacies. It advertises compounded semaglutide, compounded tirzepatide and options labeled “microdosing.” This review examines public documentation consulted October 19, 2026, rather than firsthand treatment experience. The practical goal is to identify what BioPivot documents, who is supposed to deliver each service, and which questions deserve an answer before payment, prescribing or renewal.

At a glance

Who provides care: BioPivot identifies Elite Care Health for clinical care and Rx Ave Health for pharmacy and prescription fulfillment; BioPivot describes itself as a technology platform.
Sources: [11] [9]
Published standard-program prices: Compounded semaglutide is listed at $185–$225 monthly or $400–$518 quarterly across three tiers. Compounded tirzepatide is $242–$350 monthly or $590–$900 quarterly.
Sources: [10] [5]
First-review cost conflict: The homepage advertises $0 if not approved, but the refund policy retains a $59 doctor consultation fee after a clinician rejects the requested treatment.
Sources: [11] [8]
Renewal deadline: The terms describe recurring charges immediately and every 30 days, with auto-refill cancellation at least 48 hours before the applicable monthly processing date.
Sources: [9]
Compounded products: BioPivot says its medications are custom-made preparations from licensed 503A compounding pharmacies and acknowledges that compounded medications are not FDA approved.
Sources: [8] [11]

Settle the first-payment question before starting the review

BioPivot’s most consequential cost ambiguity appears before any prescription. Its homepage says the first review is “on us” and advertises “$0 if you’re not approved.” Its cancellation policy says someone found unsuitable after provider review receives the membership payment back minus a $59 doctor consultation fee. Neither statement should be silently substituted for the other. Ask which applies to your enrollment and request the answer in writing before authorizing payment.

The policy draws another boundary at the start of clinical evaluation. If you cancel before a provider has reviewed the intake, it says you are eligible for a full refund of membership or intake fees paid. After a prescription is issued but before shipment, it describes a partial refund minus $59. However, cancellation is not guaranteed once the order has been transmitted to the pharmacy, so “not shipped yet” is not necessarily a reliable stopping point.

The homepage’s separate “from $149/mo” advertisement also needs explanation: the consulted documentation does not identify the product or conditions supporting that minimum. Treatment pages advertise 20% off the first order with BIOPIVOT20, not an ongoing discount. Ask for the actual initial charge, the amount after that promotion, and the policy governing a declined prescription. Our price-question checklist can help organize those answers without treating an introductory offer as the recurring price.

Sources: [11] [10] [8]

Ask what the payment schedule actually commits you to

BioPivot publishes monthly and quarterly choices for each standard medication tier. Semaglutide Starter is $185 monthly or $400 quarterly; Continuation is $218 or $490; Maintenance is $225 or $518. Tirzepatide Starter is $242 monthly or $590 quarterly; Continuation is $315 or $780; Maintenance is $350 or $900. These are prices for compounded products. The consulted text does not expressly specify their GLP-1 administration route, presentation or supplied quantity, so the tier names should not be treated as those details.

The microdosing page lists compounded semaglutide at $168 monthly or $370 quarterly and compounded tirzepatide at $220 monthly or $528 quarterly. Separately, the cancellation policy describes a three-month membership, while the terms authorize recurring monthly orders to be charged immediately and every 30 days. Those statements do not establish how a quarterly option is collected, whether a monthly selection carries a minimum commitment, or how much medication accompanies each shipment.

Ask BioPivot to distinguish the billing interval, membership period, medication quantity and shipping cadence on one written order summary. A 30-day recurrence is not identical to a calendar-month schedule, and a three-month membership description does not itself establish a three-month medication supply. The table highlights the questions that remain after reading the advertised figures; it does not assume quarterly prepayment or require you to choose it.

Payment descriptions that need to be reconciled before enrollment
Published option or term	Documented amount or interval	Question to resolve
Compounded semaglutide standard tiers	$185/$218/$225 monthly or $400/$490/$518 quarterly	Which tier, presentation and quantity will my order contain?
Compounded tirzepatide standard tiers	$242/$315/$350 monthly or $590/$780/$900 quarterly	How is the selected quarterly option collected?
Compounded microdosing options	Semaglutide $168 monthly or $370 quarterly; tirzepatide $220 monthly or $528 quarterly	What exactly is prescribed and supplied under this label?
Membership and recurring order	Three-month membership; monthly orders charged every 30 days	What commitment and renewal calendar apply to my selection?

Sources: [10] [5] [7] [8] [9]

Identify the organization responsible for each part of care

BioPivot’s terms identify BioPivot, LLC as the website owner and operator, but explicitly say it does not practice medicine, provide clinical care, prepare medications or dispense them. Its stated role is connecting patients with independent third parties. That distinction matters when directing a question: a billing representative’s explanation is not a prescribing decision, and the platform’s marketing language does not identify the pharmacist responsible for your particular preparation.

The homepage names Elite Care Health for clinical care, with mayur@elite-care.health and 810-348-3003. It names Rx Ave Health for pharmacy and prescription fulfillment, with info@rxave.health and (833) 360-4276. BioPivot advertises access to independent, U.S. board-certified clinical providers and state-licensed compounding pharmacies. These are the site’s credential claims, not independent verification of a clinician’s credentials, a pharmacy license or the identity of the facility that would prepare an individual order.

Ask for your treating clinician’s name and professional credential, the actual preparing and dispensing pharmacy, and the contact responsible for prescription questions. The terms also condition prescription purchases on accepting fulfillment through the platform’s pharmacies, including a contractual waiver of pharmacy choice. If using another pharmacy matters to you, resolve that before purchasing rather than assuming a prescription can be transferred into your preferred channel.

Sources: [9] [11] [8]

Prepare for a clinical decision, not an automatic approval

BioPivot describes a brief online intake reviewed by the care team before a conversation with a physician. Elsewhere it says a licensed medical provider reviews the intake and may request more information, laboratory work or a consultation before deciding. Completing the form or selecting a program does not guarantee treatment. Its statement that most applicants hear back within 48 hours concerns an initial response, not a promise of approval, prescription fulfillment or delivery.

The terms require users to be at least 18, or the local age of majority if higher. During a provider consultation, the patient must be physically in the same state as the shipping address on the account. The homepage says services may be available in all 50 states where clinically appropriate and legally permitted; that is conditional availability, not confirmation that every treatment is available at every address. Ask about your state before paying, particularly if you expect to travel.

BioPivot treats its BMI calculator as a starting point, with eligibility confirmed during assessment. Its treatment pages exclude people with a personal or family history of medullary thyroid carcinoma or MEN 2, and people who are pregnant or breastfeeding; they also say the full medical history is reviewed. These are documented provider restrictions, not a complete self-screening tool. Bring your history and questions to the clinician rather than interpreting the website as an individualized eligibility determination.

Sources: [11] [9] [10]

Get the medicine’s identity beyond the marketing label

BioPivot documents compounded semaglutide and tirzepatide, including microdosing offers, but the consulted text does not expressly establish the route of administration. Ask for the complete formulation, route, concentration, presentation, supplied quantity and preparing pharmacy before comparing an offer with another program. A familiar ingredient name does not answer those questions. Our medication-identification questions provide a way to record those details without deriving administration instructions from advertising.

The site acknowledges that compounded medications are not FDA approved and that FDA does not evaluate them for safety, effectiveness or quality. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Nonapproval alone does not establish clinical inequivalence, but neither does a pharmacy credential make a compounded preparation FDA approved. Ask the prescriber to explain the proposed preparation’s role in your care.

The word “microdosing” should prompt questions rather than assumptions about effectiveness or tolerability. BioPivot’s commercial descriptions do not establish measured outcomes for its patients. The clinical trials of semaglutide and tirzepatide in the consulted context were not studies of BioPivot, its compounded preparations, other routes or microdoses. FDA also reports measuring and administration errors with compounded GLP-1 medications, some involving hospitalization; obtain clear instructions from the prescriber or pharmacist rather than calculating a dose from a review.

Sources: [10] [5] [7] [11] [8] [1] [2] [3]

Define what support and testing are included

The terms describe a bundled subscription price covering the pharmacy’s prescription-drug fee, the medical group’s provider services and platform access. Treatment pages advertise direct physician messaging through a secure portal and structured check-ins, but do not specify their frequency. Ask who actually answers messages, how scheduled reviews occur and what happens when a concern cannot wait. The documented bundle does not resolve whether every additional consultation, required test or administration material is included.

BioPivot advertises baseline bloodwork and ongoing monitoring when a licensed provider considers them appropriate. It separately lists a Comprehensive Panel for $228.30, including blood counts, metabolic testing, thyroid tests, A1c, several hormone markers and vitamin testing. The consulted pages do not explain whether that charge is included in a program or separate. A Tasso home capillary-collection kit is labeled “coming soon,” with no price; it should not be assumed to be an available testing pathway.

General support is available at info@biopivot.co and 520-210-4673. The contact page lists clinical hours Monday through Friday, 9 a.m. to 5 p.m., without specifying a time zone in that block, and promises a contact-form response within 24 hours. Those statements do not establish round-the-clock clinical coverage. Ask about weekends, urgent concerns and response expectations using our follow-up support questions. Insurance acceptance, insurer billing and HSA/FSA use are not established by the consulted documentation.

Sources: [9] [10] [6] [11]

Know the delivery and packaging rules before shipment

BioPivot advertises compounded medication shipped on a structured cadence, with temperature-controlled, unmarked packaging and discreet delivery. The consulted documentation does not specify preparation time, dispatch time, carrier, arrival window or exact shipment frequency. Ask when tracking becomes available and whom to contact if a shipment stalls. Separately, the terms warn that prescription products will not be dispensed in child-resistant containers, an important detail to understand before deciding how to store the delivery securely.

The policy requires damaged or incorrect orders to be reported to info@biopivot.co within seven days of delivery, with photos of the packaging and product, for a no-cost replacement. For an order confirmed by tracking as lost and not delivered, it requires contact within 14 days of the expected delivery date and promises reshipment without an additional charge. These are defined incident procedures, not a general guarantee that any dissatisfaction qualifies for a refund.

Temperature concerns deserve a separate response from ordinary tracking problems. FDA explicitly advises not using an injectable GLP-1 drug that arrives warm or insufficiently refrigerated, and contacting the provider or dispensing pharmacy. That guidance is conditional on an injectable delivery; BioPivot’s consulted GLP-1 text does not expressly establish the route. Ask the pharmacy how to assess the particular shipment and how a temperature complaint is handled rather than relying on the advertising phrase “temperature-controlled.”

Sources: [10] [9] [8] [1]

Keep a written exit plan and clarify data handling

BioPivot’s cancellation policy allows requests through Account > Subscription > Cancel Membership, by email with the account name and email address, or by telephone during business hours. It says requests are processed within one business day and benefits remain through the three-month membership period. The terms add a deadline: turn off auto-refill at least 48 hours before the applicable monthly processing date. They also promise an electronic notice five to seven days before a scheduled recurring transaction.

Ask whether canceling membership also turns off auto-refill, and obtain confirmation of the final charge and remaining access. Cancellation does not itself establish refund eligibility. After compounded medication ships, sales are final except for the stated pharmacy-error or damaged/incorrect-delivery exceptions. Approved refunds are processed within five to ten business days, with another three to five business days potentially needed for bank posting. Our renewal questions can help preserve a clear record of the applicable deadline.

Privacy documentation also merits a specific question. The general policy says BioPivot does not sell, rent or trade personal information, while its California notice says certain advertising disclosures may count as a sale or sharing under that state’s law. The terms additionally reference Pura Labs LLC in a HIPAA clause without explaining its relationship to BioPivot. These documentary inconsistencies do not establish misuse or a legal conclusion; ask which entities receive intake information and what privacy choices apply.

Sources: [8] [9] [4]

Questions & answers

Is BioPivot’s first consultation definitely free?

The public documentation does not support an unqualified yes. The homepage advertises a free first review and $0 if not approved, but the cancellation policy retains a $59 consultation fee after a provider determines the requested treatment is unsuitable. Before paying, ask which rule governs your order and whether any promotion changes that policy.

Sources: [11] [8]

Does selecting monthly pricing mean there is no three-month commitment?

That is not established. Treatment pages offer monthly and quarterly prices, the cancellation policy describes a three-month membership, and the terms describe recurring monthly orders charged every 30 days. Ask for the minimum commitment, initial collection, renewal date and cancellation consequences for your specific selection. Do not assume either mandatory quarterly prepayment or a commitment-free monthly arrangement.

Sources: [10] [5] [8] [9]

Who should answer a prescription or pharmacy question?

The homepage identifies Elite Care Health for clinical care and Rx Ave Health for pharmacy and fulfillment. BioPivot says it is a technology platform rather than a medical practice or dispenser. Request your individual clinician’s and pharmacy’s details, then distinguish clinical questions from billing requests. The public partner names alone do not verify who will prepare a particular prescription.

Sources: [11] [9]

Can I use my preferred outside pharmacy?

BioPivot’s terms condition purchasing a prescription-containing service on accepting fulfillment through its pharmacy channel and include a waiver of pharmacy choice. They tell people who do not want to accept that condition not to purchase. If outside dispensing is important, obtain clarification before enrollment; the reviewed documents do not establish an alternative pharmacy pathway.

Sources: [9]

Are laboratory tests included in the advertised price?

The documentation does not clearly settle that question. BioPivot advertises clinically appropriate baseline and follow-up testing and separately lists a Comprehensive Panel at $228.30. Ask which tests your clinician may require, where collection occurs and whether collection and testing charges are additional. The Tasso home-collection option is described as coming soon, not as an established included service.

Sources: [11] [9]

What if my BioPivot order arrives damaged or incorrect?

Email info@biopivot.co within seven days of delivery and include photos of the product and packaging. The policy says BioPivot will coordinate a replacement at no cost. Lost shipments have a separate 14-day reporting window tied to the expected delivery date and tracking confirmation. For an injectable product arriving warm or inadequately refrigerated, FDA advises not using it and contacting the provider or pharmacy.

Sources: [8] [1]

Our assessment

BioPivot provides useful specifics: named care partners, published medication tiers, a bundled-service description, portal messaging and defined delivery-incident procedures. Those details make meaningful pre-enrollment questions possible. The principal unresolved issues are also material: whether an unsuccessful review costs $59, how monthly and quarterly options relate to a three-month membership, and which cancellation action prevents the next charge. Before proceeding, obtain a written order summary covering the exact preparation, responsible clinician and pharmacy, total initial and recurring charges, testing costs, supply schedule and exit deadline. Clear answers would make the documented offering easier to evaluate; the public pages alone do not resolve those points or establish treatment outcomes.

Visit BioPivot’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

BioPivot Review: Questions to Resolve Before Paying for a Compounded GLP-1 Program

At a glance

01Settle the first-payment question before starting the review

02Ask what the payment schedule actually commits you to

03Identify the organization responsible for each part of care

04Prepare for a clinical decision, not an automatic approval

05Get the medicine’s identity beyond the marketing label

06Define what support and testing are included

07Know the delivery and packaging rules before shipment

08Keep a written exit plan and clarify data handling